TW200801034A - Novel sea lice vaccine - Google Patents

Novel sea lice vaccine

Info

Publication number
TW200801034A
TW200801034A TW095135847A TW95135847A TW200801034A TW 200801034 A TW200801034 A TW 200801034A TW 095135847 A TW095135847 A TW 095135847A TW 95135847 A TW95135847 A TW 95135847A TW 200801034 A TW200801034 A TW 200801034A
Authority
TW
Taiwan
Prior art keywords
protein
nucleic acid
acid sequences
vaccines
sea lice
Prior art date
Application number
TW095135847A
Other languages
Chinese (zh)
Inventor
Petter Frost
Frank Nilsen
Lars Are Hamre
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of TW200801034A publication Critical patent/TW200801034A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to 200 kD protein, a 180 kD protein, a 100/85 kD protein and a79 kD protein. The invention further relates too nucleic acid sequences encoding a 200 kD protein, a 180 kD protein, a 100/85 kD protein and a79 kD protein, to vaccines comprising these proteins or nucleic acid sequences encoding the proteins, to DNA fragments, recombinant DNA molecules, live recombinant carriers and to host cells comprising such nucleic acid sequences, to vaccines comprising such DNA fragments, recombinant DNA molecules, live recombinant carriers and to host cells comprising such nucleic acid sequences, to methods for the preparation of such vaccines and to the use of such protein or nucleic acid sequences encoding such protein in vaccines and for the manufacture of a vaccine for combating sea lice infection in salmonids.
TW095135847A 2005-10-05 2006-09-27 Novel sea lice vaccine TW200801034A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05109261 2005-10-05
EP05109260 2005-10-05
EP05109258 2005-10-05
EP05109259 2005-10-05

Publications (1)

Publication Number Publication Date
TW200801034A true TW200801034A (en) 2008-01-01

Family

ID=37696028

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095135847A TW200801034A (en) 2005-10-05 2006-09-27 Novel sea lice vaccine

Country Status (7)

Country Link
EP (1) EP1934247A1 (en)
JP (1) JP2009511005A (en)
CA (1) CA2624486A1 (en)
DK (2) DK200800635A (en)
NO (1) NO20081541L (en)
TW (1) TW200801034A (en)
WO (1) WO2007039599A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789554B1 (en) * 2004-07-28 2018-07-04 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
CU23634A1 (en) * 2007-05-31 2011-02-24 Ct Ingenieria Genetica Biotech SEQUENCES OF NUCLEIC ACID AND AMINO ACIDS, AND VACCINE FOR THE CONTROL OF INFESTATIONS BY ECTOPARASITES IN FISH
EP2211900A1 (en) 2007-11-19 2010-08-04 Calanus AS Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
GB201902425D0 (en) * 2019-02-22 2019-04-10 Benchmark Animal Health Ltd Sea lice antigens and vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1789554B1 (en) * 2004-07-28 2018-07-04 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof

Also Published As

Publication number Publication date
EP1934247A1 (en) 2008-06-25
DK201070087A (en) 2010-03-05
CA2624486A1 (en) 2007-04-12
WO2007039599A1 (en) 2007-04-12
NO20081541L (en) 2008-07-02
JP2009511005A (en) 2009-03-19
DK200800635A (en) 2008-05-05

Similar Documents

Publication Publication Date Title
EA201071323A1 (en) AXMI-115, AXMI-113, AXMI-005, AXMI-163, AXMI-184 INSECTICIDE PROTEINS AND METHODS OF THEIR APPLICATION
NZ591415A (en) Haemophilus influenzae type B
ATE470673T1 (en) VACCINES CONTAINING LAWSONIAINTRACELLULAR SUBUNIT
IL220133A0 (en) Nucleic acid molecules and recombinant vaccines comprising sequences encoding immunogens and immunomodulators, compositions comprising said nucleic acid molecules, and uses of said nucleic acid molecules, recombinant vaccines, compositions and immunogens and immunomodulators in the preparation of medicaments and as medicaments
EA201170980A1 (en) PESTICIDAL PROTEINS AND METHODS OF THEIR APPLICATION
RU2016146198A (en) THERAPEUTIC DLL4-BINDING PROTEINS
TW201129379A (en) Anti-Orai1 antigen binding proteins and uses thereof
BR112014001978A2 (en) axmi205 variant proteins and methods for using them
HRP20130022T1 (en) Fusion proteins comprising the tumor rejection antigens ny-eso-1 and lage-1
MX2011008763A (en) Foxm1 peptides and vaccines containing the same.
TW200716166A (en) Lawsonia intracellularis immunological proteins
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
KR20090016671A (en) Replikin peptides and uses thereof
MX2019009896A (en) Axmi115 variant insecticidal gene and methods for its use.
MX2009007261A (en) Foxp3 peptide vaccine.
TW200801034A (en) Novel sea lice vaccine
ATE450545T1 (en) LAWSONIA INTRACELLULARIS SUBUNIT VACCINE
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
ZA200602107B (en) Piroplasmid vaccine
ATE450546T1 (en) VACCINES CONTAINING ORNITHOBACTERIUM RHINOTRACHEALE SUBUNIT
HUP0200832A2 (en) Babesia canis vaccine
WO2005123121A3 (en) Use of dna molecule as vaccine adjuvant
AR040830A1 (en) VACCINE TO COMBAT THE INFECTION THAT PRODUCES THE MASTITIS
AR041243A1 (en) VACCINE FOR OSTERTAGY
TH88495B (en) A new vaccine for marine parasites